🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this observational study, the investigators aim to evaluate whether chan...
Status
Unknown
Location
UZ Leuven
Start Date
2016-03-25
Trial ID
NCT03472482
Treatments Being Tested
Prospective study to assess the retinal microvasculature, optic nerve head ...
Status
Completed
Location
Cairo University teaching hospital
Start Date
2021-07-12
Trial ID
NCT04928196
Treatments Being Tested
The investigators wish to better understand the role of the choriocapillari...
Status
Unknown
Location
University of California Los Angeles Doheny Eye Institute
Start Date
2020-01-18
Trial ID
NCT04469140
Treatments Being Tested
Observational prospective cohort study designed to assess the mechanisms of...
Status
Unknown
Location
St Bartholomews Hospital
Start Date
2022-05-18
Trial ID
NCT06048458
The purpose of this study is to assess the repeatability and reproducibilit...
Status
Completed
Location
Multiple Locations
Start Date
2016-08-29
Trial ID
NCT02911883
Treatments Being Tested
Revadiab is case-control study aimed to demonstrate that retinal capillary ...
Status
Completed
Location
Hôpital Lariboisière
Start Date
2019-01-07
Trial ID
NCT03821753
This study will evaluate the effect of combination therapy with verteporfin...
Status
Terminated
Location
Novartis Investigative site
Start Date
2007-05
Trial ID
NCT00433017
Treatments Being Tested
This prospective observational study aims to understand the effects of diff...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-01
Trial ID
NCT06587776
Behcet's disease is an important cause of retinal vasculitis and vision los...
Status
Completed
Location
Faculty of medicine
Start Date
2018-03-01
Trial ID
NCT03264391
We designed this study to examine whether COVID-19 infection could lead to ...
Status
Completed
Location
Guangzhou First People's Hospital
Start Date
2023-02-01
Trial ID
NCT05952466